Construction of eukaryotic expression vector PcDNA3.0-AIF△1-480 and its apoptosis promoting activity
Qing Zhu
Abstract
Qing Zhu
Abstract
OBJECTIVE:To investigate pro-apoptotic activity of truncated human AIF and its ocular mechanisms,by constructing a novel eukaryotic expression vector which only contains promote apoptosis structure domain.METHODS:A novel eukaryotic expression vector was constructed by using polymerase chain reaction(PCR).The vector were transfected into MCF-7 cells by Lipofectamine~TM 2000 and then the pro-apoptotic activity of the eukaryotic expression vector PcDNA3.0-AIF△1-480 was detected by flow cytometry technology and at the same time through JC-1 flow cytometry technology,the mitochondrial membrane potential situation were learned.In addition,the pro-apoptotic activity of the eukaryotic expression vector were detected in vivo by constructing a tumor-burdened nude mouse model.RESULTS:We successfully constructed a novel eukaryotic expression vector.In vitro,compared to control group,the vector could induce MCF7 cells apoptosis,the apoptosis rate was 0.01%,16.01%,28.55% respectively.And then the mitochondrial membrane potential of MCF7 cells transfected by Lipofectamine~TM 2000 was depolarized,and the apoptosis rate was 2.26%,60.37%,95.78% respectively.For the tumor-burdened nude mouse model,the vector could inhibit tumor growth.The median tumor size was 1 187.2 mm~3,1 000 mm~3 and 609.4 mm~3 respectively.CONCLUSION:It confirms eukaryotic expression vector PcDNA3.0-AIF△1-480 have apoptosis activity,it may not play the active role of promoting the apoptosis in the nuclei,but play the role by changing the mitochondrial membrane potential.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To investigate pro-apoptotic activity of truncated human AIF and its ocular mechanisms,by constructing a novel eukaryotic expression vector which only contains promote apoptosis structure domain.METHODS:A novel eukaryotic expression vector was constructed by using polymerase chain reaction(PCR).The vector were transfected into MCF-7 cells by Lipofectamine~TM 2000 and then the pro-apoptotic activity of the eukaryotic expression vector PcDNA3.0-AIF△1-480 was detected by flow cytometry technology and at the same time through JC-1 flow cytometry technology,the mitochondrial membrane potential situation were learned.In addition,the pro-apoptotic activity of the eukaryotic expression vector were detected in vivo by constructing a tumor-burdened nude mouse model.RESULTS:We successfully constructed a novel eukaryotic expression vector.In vitro,compared to control group,the vector could induce MCF7 cells apoptosis,the apoptosis rate was 0.01%,16.01%,28.55% respectively.And then the mitochondrial membrane potential of MCF7 cells transfected by Lipofectamine~TM 2000 was depolarized,and the apoptosis rate was 2.26%,60.37%,95.78% respectively.For the tumor-burdened nude mouse model,the vector could inhibit tumor growth.The median tumor size was 1 187.2 mm~3,1 000 mm~3 and 609.4 mm~3 respectively.CONCLUSION:It confirms eukaryotic expression vector PcDNA3.0-AIF△1-480 have apoptosis activity,it may not play the active role of promoting the apoptosis in the nuclei,but play the role by changing the mitochondrial membrane potential.
Key concepts: Lipofectamine, Apoptosis, Transfection, Flow cytometry, Vector (molecular biology), Molecular biology, Expression vector, Biology